M. Çebi Et Al. , "CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS," Frontiers in Immunology , vol.11, 2020
Çebi, M. Et Al. 2020. CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS. Frontiers in Immunology , vol.11 .
Çebi, M., Durmus, H., Aysal, F., Özkan, B., Gül, G. E., Çakar, A., ... Hocaoglu, M.(2020). CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS. Frontiers in Immunology , vol.11.
Çebi, Merve Et Al. "CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS," Frontiers in Immunology , vol.11, 2020
Çebi, Merve Et Al. "CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS." Frontiers in Immunology , vol.11, 2020
Çebi, M. Et Al. (2020) . "CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS." Frontiers in Immunology , vol.11.
@article{article, author={Merve Çebi Et Al. }, title={CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS}, journal={Frontiers in Immunology}, year=2020}